Navigation Links


folding in Biological Technology

Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements

... chaperone," noted John Crowley. Other Protein folding and Stabilization Programs: In 2008, Amicus ... diseases that could benefit from improved protein folding and stabilization. The company's advanced ... in cells, leading to improved protein folding and trafficking, and increased activity. Amicus ...

Bioinformatics Expert Dr. Jiaan Yang Joins Sundia MediTech With Innovative PFSC Technology

... in Shanghai, China announced today that Sundia has acquired Protein folding Shape Code (PFSC) technology for doing probe binding site for drug ... applied mathematics on this biology subject, generated a set of Protein folding Shape Code (PFSC) for a complete description of protein's complex 3D ...

First ASMS Hites Award for Outstanding Research Publication Presented to Prof. Alison Ashcroft for Her Use of Waters Synapt HDMS System to Explore Protein Complexes

... paper titled, Monitoring Copopulated Conformational States During Protein folding Events Using Electrospray Ionization-Ion Mobility Spectrometry-Mass ... is: Monitoring co-populated conformational states during protein folding events using ESI -IMS-MS, D. P. Smith, K. Giles, R. H. Bateman, S. E. ...

BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco

... Target Underlying Defect in Cystic Fibrosis; CFTR folding and Transport NOVATO, Calif., Aug. 22 /PRNewswire-FirstCall/ -- ... and have demonstrated a high degree of potency and specificity for the folding and activation of the abnormal CFTR protein. We look forward to ...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results Release Date

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

DNA Software, Inc. Awarded $2.5 M in NIH Funding to Develop Pioneering Nucleic Acid-based Technologies

... and therapeutics. OMP™ (Oligonucleotide Modeling Platform™), the core engine that runs all of DNA Software's tools, models in silico the folding and hybridization of nucleic acids with exception accuracy. Visual OMP™ is a platform program for the design, simulation, and analysis of ...

Canadian researchers discover gene related to the appearance of aging

... health benefits. However, proline is not completely understood. Researchers know that it helps make 'kinks' in protein chains, critical for correct folding of these proteins. But it seems to play an independent role in protection from cellular stress. Proline made internally in our bodies may have a ...

Amicus Therapeutics to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 13, 2009

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics Announces First Quarter 2009 Financial Results Release Date

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

DNA Software, Inc. Honored as One of the 2009 "Michigan 50 Companies to Watch"

... and therapeutics. OMP™ (Oligonucleotide Modeling Platform™), the core engine that runs all of DNA Software's tools, models in silico the folding and hybridization of nucleic acids with exception accuracy. Visual OMP™ is a platform program for the design, simulation, and analysis of ...

Amicus Therapeutics to Present at the 16th Annual Future Leaders in the Biotech Industry Conference

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics Presents Positive Results From Phase 2 Extension Study of Amigal(TM) for Fabry Disease at ACMG 2009 Annual Meeting

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics to Present at the Cowen and Company 29th Annual Healthcare Conference on March 17, 2009

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics Announces Change to Board of Directors

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics Adds Sol J. Barer, Ph.D. to Board of Directors

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics to Present at Lazard Capital Markets Healthcare Conference

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Could Database Software Help Cure Alzheimer's and Save the Earth?

... Parkinson's disease, emphysema and cystic fibrosis. Because experimental approaches provide only limited amounts of information about the actual folding process, Daggett Research Group employs computer simulations, which generate massive amounts of data that must be analyzed. The lab has already ...

Amicus Therapeutics Announces Third Quarter 2008 Financial Results

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics Announces Third Quarter 2008 Results Release Date

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics to Present at the 2008 UBS Global Life Sciences Conference

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics Opens Research Facility in San Diego

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics to Present at the 2008 BioCentury NewsMakers in the Biotech Industry Conference

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics Announces Second Quarter 2008 Results Release Date

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Boys in the Hood

... You Need table, heading their list was an emergency escape hood worthy of James Bond: a one size fits all concealable hood weighing under a pound, folding to the dimensions of a DVD case, and donnable in ten seconds. Furthermore, the hood must be maintenance-free, filter nerve, blood, and blister ...

Cystic Fibrosis - Axentis Pharma Takes Over Patents and Continues Development of Innovative Platform Technology

... Swiss biotechnology company. The company is using a patent-pending platform technology to develop therapies for diseases caused by incorrect protein folding in the endoplasmic reticulum. The most prominent example of such diseases is cystic fibrosis (mucoviscidosis). The company is in final preparation to ...

Studies Show USGI Medical's EndoSurgical Operating System(TM) Enables Incisionless Surgery to Reduce Gastric Pouch and Stoma After Gastric Bypass

... precision and control; allows the use of multiple, robust instruments for two-handed operation and enables rapid, durable suturing for tissue folding and wound closure. About USGI Medical USGI Medical is the leader in Incisionless Surgery. USGI's EndoSurgical Operating System(TM) (EOS) provides ...

Amarin Announces Completion of the First Tranche of $60 Million Private Placement

... 1995. Dr. Gordon received a Ph.D. in Molecular Biology from the Massachusetts Institute of Technology. His doctoral work involved studies of protein folding and assembly. He received a Bachelors degree from Harvard College. Dr. Eric Aguiar is a Partner at Thomas, McNerney & Partners. He has 16 years of ...

Amicus Therapeutics Announces First Quarter 2008 Financial Results

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Boys in the Hood

... You Need table, heading their list was an emergency escape hood worthy of James Bond: a one size fits all concealable hood weighing under a pound, folding to the dimensions of a DVD case, and donnable in ten seconds. Furthermore, the hood must be maintenance-free, filter nerve, blood, and blister ...

Foldable and stretchable, silicon circuits conform to many shapes

... circuit that can wrap around complex shapes such as spheres, body parts and aircraft wings, and can operate during stretching, compressing, folding and other types of extreme mechanical deformations, without a reduction in electrical performance. The notion that silicon cannot be used in such ...

Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women

... said Kari Stefansson, CEO of deCODE. "We are also excited that we can now immediately enable individuals to see if they carry such variants, by folding the findings announced today -- and others we expect to publish in the near future -- into our deCODEme(TM) personal genome analysis service." The ...

Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...

Amicus Therapeutics to Host R&D Day

... chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with ...
Other Contentshyperventilationhypocalcemiahypocalcemiahypodermichypodermic
(Date:11/23/2009)...d strain of the deadly superbug MRSAan infection-c...csposes a far greater health threat than previousl...rding to a study in the December issue of Emergin...ily picked up in fitness centers, schools, and oth...den of MRSA within hospitals, the report found. ,...
(Date:11/23/2009)...n Society says that western lowland gorillas livin... the "mother lode" of more than 125,000 gorillas d...tened by growing humans activity in the region. ,...ests adjacent to the southwest border of Lac Tl Co...t high densities of the great apes still exist in ...
(Date:11/23/2009)...incontrovertible evidence" that the volcanic super...3,000 years ago deforested much of central India, ...eport. , The volcano ejected an estimated 800 cu... a crater (now the world,s largest volcanic lake) .... Ash from the event has been found in India, the ...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Businesses Unions Veteran Party Leaders Unite Behind Bipartisan Consensus Approach to Health Care Reform 48325 1Businesses Unions Veteran Party Leaders Unite Behind Bipartisan Consensus Approach to Health Care Reform 48325 2Businesses Unions Veteran Party Leaders Unite Behind Bipartisan Consensus Approach to Health Care Reform 48325 3Businesses Unions Veteran Party Leaders Unite Behind Bipartisan Consensus Approach to Health Care Reform 48325 4Businesses Unions Veteran Party Leaders Unite Behind Bipartisan Consensus Approach to Health Care Reform 48325 5Businesses Unions Veteran Party Leaders Unite Behind Bipartisan Consensus Approach to Health Care Reform 48325 6Businesses Unions Veteran Party Leaders Unite Behind Bipartisan Consensus Approach to Health Care Reform 48325 7Impliant Granted Two New U S Patents and Successfully Defends European Patent Opposition Case 48321 1Impliant Granted Two New U S Patents and Successfully Defends European Patent Opposition Case 48321 2White Paper Explains Package Validation Requirements For Medical Devices 26 Combinatory Products 48317 1White Paper Explains Package Validation Requirements For Medical Devices 26 Combinatory Products 48317 2White Paper Explains Package Validation Requirements For Medical Devices 26 Combinatory Products 48317 3
(Date:11/25/2009)...e/--TheBartleHallConventionCenterwilltemporarilybe...KansasCityhoststhelatestinaseriesofmassivefreeclin...asthepotentialtobethebiggestoneyet,becauseitwillex...insteadofoveraweekend,"SheriWood,executivedirector...tionalAssociationofFreeClinics(NAFC). ,, Atprev...
(Date:11/25/2009)...inelleMedicalInc.,aleadingmanufacturerofbreastMRIc...ofnewleadingedgeclinicalapplicationsonitsAegis(TM)...icalSocietyofNorthAmerica(RSNA)annualmeetinginChic...ionsleveragetheuniquehighqualityimagesgeneratedbyS...tipleimagingmodalitiesformulti-parametricassessmen...
(Date:11/25/2009)...Newswire/--TheBlackAIDSInstituterecentlyheldBoardo...r2010. ,, ThenewBoardMembersareahighlydiversegr...nce,governmenthealthprograms,editorial,andbusiness...personalbackgroundsincludingbothheterosexualandgay...presentingmultipleagegroups. ,, (Photo: http://...
(Date:11/25/2009)...cer who were treated with cisplatin-based chemothe...logical side effects and Raynaud-like phenomena, t...cording to a new study published online November 2... . , Marianne Brydy, M.D., of the Department of ..., Norway, and colleagues conducted a cross-section...
(Date:11/25/2009)... This simple question has been the focus of intens...e Modulates High Blood Pressure in Mice & Men, Do...estion has been the focus of intense research for ...me established a link between a novel gene, phosdu...mice as well as humans. The studies were directed ...
Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:New stress-related gene modulates high blood pressure in mice and men 2
Other TagsEKEEFREFREFREFRDNEDNEDNEDNEDNEDNEDNEDDLOther Tagsobservations 2observations 3observations 4observations 5observations 6observations 7scarcity 2isolation 2isolation 3significantly 2significantly 3significantly 4significantly 5significantly 6significantly 7significantly 8significantly 9significantly 10